Treatments For Prostate Cancer

Posts Tagged ‘treatment’

Product Description
Over the last several decades epidemiological, human migratory studies, pre-clinical and even early phase clinical trials have suggested that dietary constituents may offer a protective effect in reducing the incidence of multiple cancers, including cancer of the prostate. Given the potential that some of these compounds have shown in pre-clinical and even some clinical investigations, it is essential to further identify and develop promising new agents in the hope of creating a broad spectrum of cancer chemopreventive agents. In our studies, we characterized two agents for prostate cancer chemoprevention: carnosol and alpha-mangostin. Carnosol, a dietary diterpene, found in Mediterranean herbs including basil, oregano, sage, and thyme has been shown to decrease prostate cancer cell viability. In our analysis we found carnosol to function as a dual disruptor of the androgen and estrogen receptor-alpha using in vitro and in vivo models. Further study found these traits to be unique when compared to FDA approved anti-androgens and anti-estrogens. alpha-Mangostin, a dietary xanthone, isolated from the mangosteen fruit, was also observed to decrease prostate cancer cell viability. We evaluated alpha-mangostin for kinase inhibition against 50 different kinases. Of those, alpha-mangostin was found to be most effective against CDK4. Our analysis describes the in vitro and in vivo inhibition of prostate cancer using alpha-mangostin. We are proposing that alpha-mangostin and carnosol have unique mechanisms of action and may be further developed as cancer chemopreventive agents.

Selected plant constituents for the prevention and treatment of prostate cancer.

newprostatecancertreatmentsandnews.blogspot.com www.facebook.com prostatecancertreatmentcures.blogspot.com All the new and latest best treatments for prostate cancer are detailed here

Product Description
The genetic and biochemical diversity of marine microorganisms makes them a promising source of useful pharmaceutical agents. The marine cyanobacterium Lyngbya majuscula produces a large number of lipopeptides that are ligands for the voltage-gated sodium channel (VGSC). Compounds that block sodium channel current are known to be effective as anticonvulsants, anesthetics, and anti-arrthymic drugs. In addition, the expression of VGSC’s was found to correlate with the metastatic potential of prostate cancer cells, indicating that sodium channel blockers could have therapeutic use as prostate cancer drugs. The jamaicamides are lipopeptides isolated from L. majuscula that exhibit sodium channel blocking activity at 5 muM. They share a common pharmacophore with the hermitamides, another class of lipopeptides isolated from the same cyanobacterium. The hermitamides are structurally less complex than the jamaicamides but have not been tested for sodium channel activity. Herein, we report the enantioselective synthesis of the hermitamides, their sodium channel activity, and effects on prostate cancer cell proliferation. We also report the enantioselective synthesis of jamaicamide C carboxylic acid. Additional work is reported targeting the dimerization interface of core binding factor (CBF), a protein implicated in the development of acute myelogenous leukemia (AML). A lead compound was designed using computational screening, NMR spectroscopy and x-ray crystallography. A large series of analogues was synthesized and tested for their ability to inhibit dimerization. We have identified several analogues that potently bind to CBF, inhibit dimerization and block proliferation of AML leukemia cell lines.

Synthesis and discovery of lipopeptides from marine sources as sodium channel blockers for the treatment of prostate cancer.

Product Description
PAU D’ARCO TEA has shown that it may hold the secret for the successful treatment of cancer and other diseases.

Pau D’Arco Tea 48 Bags

Product Description
Personal stories show men how to make the right decisions for themselves, with medical insights from a leading Johns Hopkins authority on prostate cancer

If you or someone you know has been diagnosed with prostate cancer, you want to know the facts about treatment options as well as what to expect through the process of treatment and recovery.

Written by Dr. Arthur L. Burnett, II. one of the world’s most distinguished authorities on prostate cancer and veteran CBS News journalist and prostate cancer survivor, Norman Morris, Prostate Cancer Survivors Speak Their Minds gives you the information you need through the experiences of men who have had prostate cancer. Dr. Burnett speaks openly and honestly about prostate cancer options, treatments, and aftereffects and shares stories of both well-known and ordinary prostate cancer survivors who offer their personal reflections on going through treatment and getting well.

• Includes personal stories from notable prostate cancer survivors such as Arnold Palmer, Ken Griffey Sr., Pat Robertson, and others
• Takes an authoritative look at prostate cancer treatments, current and promising  scientific breakthroughs, and life-altering side effects
• Author Arthur Burnett, a leading prostate cancer expert, is the Patrick C. Walsh Professor of Urology, Cellular and Molecular Medicine at the Johns Hopkins’s James Buchanan Brady Urological Institute and is renowned for his research studies that led to the formulation of Viagra
• Offers solutions to common side effects such as sexual problems and incontinence

Combining the essential medical facts about prostate cancer with personal, intimate stories told by courageous men who have survived it, this book is an invaluable guide for men diagnosed with prostate cancer and those who care about them.

Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects

I am looking for the 2010 numbers of these treatments for prostate cancer, both in the US and in Europe. I am not looking just for prostate cancer incidence, but treatments numbers broken out by treatment modality.

I was wondering if anyone knew how the green light laser prostate cancer treatment worked. i found http://www.birminghamprostateclinic.co.uk/greenLightLaser.php which has some good information but I need a bit more detail.

On Monday i went to the doctor due a enlarged testicle, on weds i had an ultrasound and they confirmed a mass inside it. Today i went for a cat scan of my abdomen. Although not confirmed as cancer can people give me some rough guide to what i can expect over what timescales if it is cancerous. Is it a high likely hood that chemo will be used? Any experiences would be greatly recieved.

I am looking for the 2010 numbers of these treatments for prostate cancer, both in the US and in Europe. I am not looking just for prostate cancer incidence, but treatments numbers broken out by treatment modality.